DUBLIN, Jan 13, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Protein Therapeutics Market 2017-2021" report to their offering.
The report forecasts the global protein therapeutics market to grow at a CAGR of 7.86% during the period 2017-2021.
The latest trend gaining momentum in the market is emergence of next-generation biologics. Next-generation biologics market is evolving at a rapid pace. Although most of the next-generation biologics are the improvised versions of existing first-generation drugs, they are slated to achieve wider acceptance attributed to their reduced immunogenicity primarily.
According to the report, one of the major drivers for this market is increased demand for mAbs. Monoclonal antibodies represent a major segment of the global protein therapeutics market. The understanding of diseases at the molecular level increases the development and use of mAbs in their treatment. These antibodies have a high affinity toward specific disease cells and areas that need to be treated. There is a remarkable increase in the use of mAbs in various therapies such as radioimmunotherapy and antibody-directed enzyme prodrug therapy.
Further, the report states that one of the major factors hindering the growth of this market is complexities in manufacturing, storage conditions, distribution policies, and high cost. Unlike small molecule drugs, proteins are prepared from living organisms. Hence, the manufacturing process involved is very complex and time-consuming. The process involves steps such as fermentation, clarification, separation, and purification. The process of separation is also difficult as different molecules differ slightly from each other. The purification process is also lengthy, and the risk of contamination is high as the drug is produced in the biological medium.
- F. Hoffmann-La Roche
- Johnson & Johnson
- Novo Nordisk
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product type
Part 07: Market segmentation by therapy area
Part 08: Market segmentation by protein function
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/xmwh8l/global_protein
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-protein-therapeutics-market-to-grow-7-by-2021-product-type-therapy-area--protein-function---key-vendors-are-abbvie-amgen--merck-300390831.html
SOURCE Research and Markets